Appropriate Use Criteria (AUC)

Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.

Comments or Questions?

The SNMMI Guidance Oversight Committee is continually developing new Appropriate Use Criteria (AUC) and reviewing and updating existing AUC. If you have specific comments or questions on the content of any of the AUC, or if you have suggestions for new AUC that you feel should be written, please contact the SNMMI Guidance Oversight Committee at auc@snmmi.org. All comments will be considered in the AUC development process.

 

Approved

Date Approved

Last Update

Document Title

September 27, 2019  

Gastrointestinal Transit (*will be Submitted to JNM for publication October 2019)

September 27, 2019  

Prostate Cancer Imaging (*will be Submitted to JNM for publication October 2019)

September 27, 2019  

Nuclear Medicine in the Diagnosis and Treatment of Thyroid Cancer (to include I-123 & I-131 tracers) (*will be Submitted to JNM for publication October 2019)

September 9, 2017 September 2019

Somatostatin Receptor PET Imaging in Neuroendocrine Tumors 

June 9, 2017 June 2019

FDG PET/CT Restaging and Response Assessment of Malignant Disease

June 5, 2017 June 2019

Hepatobiliary Scintigraphy in Abdominal Pain

January 20, 2017 June 2019

Ventilation/Perfusion (V/Q) Imaging in Pulmonary Embolism

January 20, 2017 June 2019

Bone Scintigraphy in Prostate and Breast Cancer

January 28, 2013  

Amyloid Imaging

Currently Under Development

PET Myocardial Perfusion Imaging (MPI)

Infection Imaging

To Be Developed

Renal Imaging

Radium 223

Lymphoscintigraphy

Brain Imaging with HMPO and DAT

Imaging and Therapy of Benign Tumors (including Graves Disease and Radio Iodine Ablation)

Feedback

Please let us know if you have any suggestions for future topics for AUC development, or any feedback on the existing publications by contacting us at auc@snmmi.org.

Available for Public Comment

As part of the development process, the SNMMI Guidance Oversight Committee will seek public comment on draft documents in order to ensure we are creating the most accurate guidelines. To submit comments on an AUC, please complete the response form and submit to auc@snmmi.org. Below are AUC for which we are currently seeking public input:

Comments Due By

 

Document Title